USPTO serial 78806400
THERAJECT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PERKINS, ELLEN J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THERAJECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas D. Foster
Thomas D. Foster TheraJect, Inc.Attn: Dr. Sung-Yun Kwon39270 Paseo Padre #112Fremont, CA 94538Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Transdermal patches for use in the treatment of cardiological, cardiovascular, antiischemic and neurological diseases, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional diseases, nutritional deficiencies, metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases and conditions of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, disease of the genitourinary system, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities injury, poisonings and addictions; transdermal patches for use in the delivery of anti-virals, anti-biotics, hormones, growth regulators, drugs regulating cardiac action, drugs regulating blood flow, drugs for the treatment of pain, drugs for the treatment of diabetes; drugs for treatment of arthritis; drugs for treatment of migraine headaches, drugs for the treatment of glaucoma, drugs for the treatment of poisonings and addiction to narcotics, stimulants and nicotine, drugs for appetite suppression; transdermal patches for use in the delivery of vaccines, namely, Hepatitis B vaccine, HIV vaccine, Influenza vaccine, Diphtheria vaccine, Tetanus vaccine, Pertussis vaccine, Lyme disease vaccine, Rabies vaccine, Pneumococcus vaccine, Yellow fever vaccine, Cholera vaccine, Vaccinia vaccine, Tuberculosis vaccine, Rubella vaccine, Measles vaccine, Mumps vaccine, Rotavirus vaccine, Botulinum vaccine, Herpes virus vaccine; transdermal patches for use in the delivery of essential amino acids, fats and vitamins; transdermal patches for use in the monitoring of glucose levels in the blood; transdermal patches for use in the delivery of medicated skincare preparations, namely, ophthalmic muscle relaxant and hydroxyacid preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 5, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 9, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 9, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 25, 2008 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Aug 25, 2008 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 25, 2008 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Aug 12, 2008 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 12, 2008 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 4, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 3, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 4, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 11, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 3, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 2, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 31, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2007 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 19, 2007 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 19, 2007 | RFTP | REMOVED FROM TEAS PLUS | — |
| Mar 18, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 23, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 1, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 1, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 27, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2007 | ALIE | ASSIGNED TO LIE | — |
| Dec 27, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 30, 2006 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 30, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 26, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 6, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 25, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2006 | NWAP | NEW APPLICATION ENTERED | — |